The 2nd Affiliated Hospital of Harbin Medical University
Welcome,         Profile    Billing    Logout  
 28 Trials 
106 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yu, Bo
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting
4
8250
RoW
Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy
Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases
04/25
04/25
NCT03273023: PROMUS PREMIER™ China Post-Approval Study

Active, not recruiting
N/A
2059
RoW
Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System
Boston Scientific Corporation
Coronary Artery Disease
12/20
02/25
NCT03491956: Double Filtration Plasmapheresis (DFPP) and Lipid Metabolism

Recruiting
N/A
30
RoW
DFPP
Shanghai Pudong Hospital
DFPP and Platelet Function
04/21
04/21
OPTIMAL, NCT03084991: OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarction

Recruiting
N/A
4500
RoW
Harbin Medical University, Abbott
Acute Myocardial Infarction
07/21
12/22
PIONEER, NCT04045873: Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI

Not yet recruiting
N/A
306
NA
extracorporeal membrane oxygenation, intra-aortic balloon pump
Xijing Hospital, The First Affiliated Hospital of Zhengzhou University, Bethune International Peace Hospital, Beijing Anzhen Hospital, The Second Affiliated Hospital of Harbin Medical University, The General Hospital of Northern Theater Command
Coronary Artery Disease, Heart Failure
07/21
06/24
NCT03062826: EROSION II: OCT Guided PPCI in STEMI

Active, not recruiting
N/A
347
RoW
dual antiplatelet therapy (aspirin + ticagrelor or aspirin + clopidogrel)
Harbin Medical University, Shenzhen Salubris Pharmaceuticals Co., Ltd., Beijing Luhe Hospital, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, The First Affiliated Hospital of Dalian Medical University, Shanxi Cardiovascular Hospital, Second Hospital of Shanxi Medical University, Hebei General Hospital, General Hospital of Ningxia Medical University, Sichuan Provincial People's Hospital, Affiliated Hospital of Jiangsu University, Xiamen Cardiovascular Hospital, Xiamen University, Shenzhen Sun Yat-sen Cardiovascular Hospital, LanZhou University, Sir Run Run Shaw Hospital, Wuhan Asia Heart Hospital
ST-segment Elevation Myocardial Infarction
02/22
03/23
EMPOWER, NCT04289480: Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms

Active, not recruiting
N/A
164
RoW
ENTERPRISE 2 device
Medos International SARL, Johnson & Johnson Medical (Shanghai) Ltd.
Intracranial Aneurysm
04/22
01/27
NCT05015699: A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI

Withdrawn
N/A
285
NA
HT Supreme
Sino Medical Sciences Technology Inc., The Second Affiliated Hospital of Harbin Medical University
Coronary Artery Disease
09/22
07/25
COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction

Recruiting
N/A
250
RoW
Dexmedetomidine (DEX), Placebo (Saline)
Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd.
ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection
12/24
12/25
DCB-ACS, NCT04937803: Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes

Completed
N/A
216
RoW
Drug-coated balloon, Zotarolimus-Eluting Coronary Stent
Harbin Medical University, Daqing Oil Field Hospital, Sichuan Provincial People's Hospital, Tianjin People's Hospital, Peking University First Hospital, Beijing Friendship Hospital, The Third Medical Center, Chinese PLA General Hospital, Jining Medical University, Fuwai Central China Cardiovascular Hospital, The First Hospital of Jilin University, General Hospital of Taiyuan Iron & Steel Company, Tongji Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital of Zhengzhou University, Sir Run Run Shaw Hospital, Inner Mongolia People's Hospital
Drug-Coated Balloon, De Novo Stenosis, Acute Coronary Syndromes, ACS, DCB, Clinical Trial, Coronary Artery Disease
02/23
11/23
NCT05750082: The AIPLAQUE Study: An Artificial Intelligence-based Prospective Study to Analyze PLAQUE Using CCTA

Recruiting
N/A
100
RoW
CCTA CT-FR CAG OCT
Harbin Medical University
Coronary Artery Disease Acute Coronary Syndrome Myocardial Ischemia Plaque Characterization
09/23
12/23
NCT05818098: Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)

Recruiting
N/A
189
RoW
Intravascular Lithotripsy System of Shanghai MicroPort Rhythm
Shanghai MicroPort Rhythm MedTech Co., Ltd.
Coronary Artery Calcification
09/23
03/24
SSPC, NCT05296876: Evaluation on Carotid Artery Stenosis After Endarterectomy

Recruiting
N/A
200
RoW
Carotid endarterectomy (CEA)
Shanghai Pudong Hospital
Carotid Stenosis, Carotid Artery Diseases, Carotid Artery Plaque
11/23
11/23
NCT06154395: Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction

Recruiting
N/A
90
RoW
OCT-guided PCI, 60 MHz HD-IVUS-guided PCI, Angiography-guided PCI
Harbin Medical University
Intravascular Imaging and Microvascular Obstruction
12/24
06/25
NCT05795829: Ultrasound Ablation for Essential Hypertension(FIM)

Recruiting
N/A
10
RoW
disposable intravascular ultrasound ablation catheter and ultrasound ablation instrument
Lepu Medical Technology (Beijing) Co., Ltd.
Uncontrolled Essential Hypertension
12/23
02/24
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

Recruiting
N/A
1860
RoW
Drug-coated balloon, Guideline-directed medical treatment
Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd
Acute Coronary Syndrome (ACS)
12/27
12/30
CIVILIAN, NCT05473884: Lesion Preparation in Femoropopliteal Artery Occlusion Disease

Recruiting
N/A
800
RoW
lesion preparation devices, Chocolate balloon, Shockwave balloon, Rotarex, TurboHawk, Jetstream, conventional balloon
Shanghai Pudong Hospital, RenJi Hospital, Shanghai Zhongshan Hospital, Huashan Hospital, First Affiliated Hospital of Zhejiang University, Xuanwu Hospital, Beijing, Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology, Second Affiliated Hospital of Soochow University, Qingdao Hiser Medical Group
Femoropopliteal Artery Occlusion, Atherosclerosis Obliterans, Lesion; Vascular, In-stent Restenosis
05/24
05/24
KY2023-156-1, NCT06449274: RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial

Recruiting
N/A
180
RoW
Drug-coated balloon, Guideline-directed medical treatment
Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd
Acute Coronary Syndrome (ACS)
06/26
06/26
MOOP-CAD, NCT06489119: Single-cell Multi-omics Analyses of OCT-diagnosed Plaque Subtypes in Coronary Artery Disease

Recruiting
N/A
350
RoW
Harbin Medical University
Coronary Artery Disease
01/26
07/26
NCT06101888: Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR)

Recruiting
N/A
116
RoW
TaurusTrio™ Heart Valve System
Peijia Medical Technology (Suzhou) Co., Ltd.
Aortic Regurgitation
07/24
07/29
OUFR, NCT06726252: Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio

Recruiting
N/A
114
RoW
FFR measurement and intravascular imaging
Harbin Medical University, Peking University Third Hospital, Panovision, Capital Medical University, The Second Affiliated Hospital of Harbin Medical University, The affiliated hospital of Jining medical college, Peking University First Hospital
Fractional Flow Reserve, Coronary Artery Disease
12/25
12/25
NCT05862103: Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

Recruiting
N/A
15000
RoW
Treatment Strategies
Yu Bo
Acute Myocardial Infarction, Adverse Event
08/25
12/26
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28
Zhang, Jianguo
NCT04244513: Deep Brain Stimulation Treatment for Chorea in Huntington's Disease

Recruiting
N/A
40
RoW
Deep brain stimulation
Beijing Municipal Administration of Hospitals, Medtronic
Huntington Disease, Deep Brain Stimulation
06/23
12/23
NCT05993117: Rechargeable Implantable Vagus Nerve Stimulation System for Drug-Refractory Epilepsy

Recruiting
N/A
20
RoW
G114R VNS system
Beijing Pins Medical Co., Ltd, Peking University First Hospital, Beijing Tiantan Hospital
Drug-Refractory Epilepsy
06/24
12/24
NCT02251808: Satisfaction Survey on PINS Stimulator System for Patients With Parkinson's Disease

Recruiting
N/A
612
RoW
Beijing Pins Medical Co., Ltd, Beijing Tiantan Hospital
Parkinson's Disease
09/24
09/24
NCT06498934: Deep Brain Stimulation of the Dentate Nucleus for Motor Rehabilitation After Stroke

Not yet recruiting
N/A
52
RoW
deep brain stimulation, Rehabilitation
Beijing Municipal Administration of Hospitals, Beijing Pins Medical Co., Ltd
Stroke, Upper Extremity Paresis
12/26
12/27
MEIGES, NCT05416905: Deep Brain Stimulation for Idiopathic Craniofacial Dystonia: GPi or STN

Recruiting
N/A
110
RoW
STN-DBS, subthalamic necleus-deep brain stimulation, GPi-DBS, globus pallidus internus-deep brain stimulation
Beijing Tiantan Hospital, Peking Union Medical College Hospital, Peking University People's Hospital, Civil Aviation General Hospital, Chinese PLA General Hospital, Beijing Pins Medical Co., Ltd
Craniofacial Dystonia, Deep Brain Stimulation
09/24
09/24
Chen, Yu
NCT04766307: A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Recruiting
4
1100
RoW
Interleukin-2, IL-2
Beijing Chest Hospital
Tuberculosis, Pulmonary
12/21
12/21
TB-TRUST, NCT03867136: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

Completed
4
354
RoW
PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter Regimen
Huashan Hospital
Multidrug Resistant Tuberculosis
08/24
08/24
NCT06041425: The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

Completed
4
40
RoW
Oxycodone, preemptive analgesia, Sufentanil
The First Affiliated Hospital with Nanjing Medical University
Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain, Inflammation
12/23
12/23
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Recruiting
4
364
RoW
Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline
Shanghai Pulmonary Hospital, Shanghai, China
Bronchiectasis Adult, Pseudomonas Aeruginosa Infection
10/25
12/25
MRG002-006, NCT04839510: A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer

Recruiting
2
58
RoW
MRG002
Shanghai Miracogen Inc.
Locally Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma
06/22
09/22
NCT05114603: A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation

Recruiting
2
30
RoW
HLX208
Shanghai Henlius Biotech
Advanced Melanoma
08/23
08/24
NCT05823246: Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

Recruiting
2
66
RoW
QLF31907
Qilu Pharmaceutical Co., Ltd.
Melanoma, Urothelial Carcinoma
10/23
07/24
NCT04614740: The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors

Recruiting
2
115
RoW
VC004
Jiangsu vcare pharmaceutical technology co., LTD
Locally Advanced Solid Tumor, Metastatic Solid Tumor
01/24
06/24
NCT05664139: Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma

Not yet recruiting
2
30
NA
Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
Fujian Cancer Hospital, Jiangsu Hengrui Pharmaceutical Co., Ltd., SunWay Biotech Co., LTD.
Malignant Melanoma, Liver Metastases
12/24
12/25
NCT06081920: A Study of IBI363 in Subjects With Advanced Melanoma

Recruiting
2
120
RoW
IBI363
Innovent Biologics (Suzhou) Co. Ltd.
Melanoma
06/25
07/26
NCT04135456: The Optimal Dose of Mannitol for Intraoperative Brain Relaxation During the Operation of Aneurysmal Subarachnoid Hemorrhage

Active, not recruiting
1/2
99
RoW
Mannitol
Beijing Tiantan Hospital
Aneurysmal Subarachnoid Hemorrhage
11/23
01/24
NCT05148533: A Study of Single Drug TJ011133 and Toripalimab Combine Treatment for Advanced Solid Tumor

Terminated
1/2
7
RoW
TJ1133 Injection
TJ Biopharma Co., Ltd.
Advanced Solid Tumor
02/23
02/23
PM8002-A001, NCT05918445: PM8002 in the Treatment of Patients With Advanced Solid Tumors

Recruiting
1/2
380
RoW
PM8002
Biotheus Inc.
Malignant Neoplasm
11/25
11/25
NCT06214156: A Clinical Study of T3011 in Subjects With Advanced Melanoma

Recruiting
1/2
42
RoW
T3011
Shanghai Pharmaceuticals Holding Co., Ltd
Advanced Melanoma
09/25
09/25
NCT05944224: A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.

Recruiting
1/2
63
RoW
SPH4336, Cadonilimab
Shanghai Pharmaceuticals Holding Co., Ltd
Advanced Solid Tumors
05/25
12/25
KY-0118-ZJKY, NCT06175780: Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Recruiting
1
189
RoW
KY-0118
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Neoplasms, Neoplasms by Histologic Type
12/25
12/25
NCT04773951: A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

Recruiting
1
156
RoW
JS004, a recombinant humanized, IgG4κ monoclonal antibody (mAb) specific to B- and T-lymphocyte attenuator (BTLA); Toripalimab Injection
Shanghai Junshi Bioscience Co., Ltd.
Melanoma, Renal Carcinoma, Urothelial Carcinoma
02/24
08/24
NCT05989958: The Safety and Tolerability Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure

Recruiting
1
12
NA
HepaCure
Hexaell Biotech Co., Ltd.
Acute on Chronic Hepatic Failure, Liver Failure, Hepatitis
09/24
09/24
NCT04936178: A Study of NB003 in Patients With Advanced Malignancies

Recruiting
1
258
Europe, US, RoW
NB003 tablets
Ningbo Newbay Technology Development Co., Ltd
Advanced Solid Tumor
07/25
12/25
ADRX-0706-001, NCT06036121: A Study of ADRX-0706 in Select Advanced Solid Tumors

Recruiting
1
144
US, RoW
ADRX-0706
Adcentrx Therapeutics
Solid Tumors, Triple Negative Breast Cancer (TNBC), Urothelial Cancer, Cervical Cancer
09/25
12/26
TB-TRUSTplus, NCT04717908: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

Completed
N/A
89
RoW
Bedaquiline, BDQ, Pyrazinamide, PZA, Linezolid, LZD, Cycloserine, Cs, Clofazimine, CFZ
Huashan Hospital
Multidrug Resistant Tuberculosis
06/24
06/24
NCT04968028: Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament

Recruiting
N/A
164
RoW
ACAF, Anterior Controllable Antedisplacement and Fusion, Laminoplasty
Shanghai Changzheng Hospital, Changhai Hospital, Shanghai 6th People's Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Tongji Hospital, Peking University Shenzhen Hospital, The Second Affiliated Hospital of Harbin Medical University, Xuanwu Hospital, Beijing, Jining Medical University, The Affiliated Hospital of Qingdao University, Shanxi Bethune Hospital, Tang-Du Hospital
Ossification of Posterior Longitudinal Ligament, Cervical Spondylosis With Myelopathy
07/25
12/26
rTMS, NCT06145932: Repetitive Transcranial Magnetic Stimulation Therapy in Essential Tremor

Recruiting
N/A
40
RoW
real rTMS, sham rTMS
Second Affiliated Hospital of Soochow University
Essential Tremor
10/26
12/26
GES-aSAH, NCT06346015: Gamma Entrainment Stimulation for Cognitive Dysfunction After aSAH

Not yet recruiting
N/A
60
NA
Gamma Entrainment Stimulation, Audio-assistied therapy
Beijing Tiantan Hospital, Shanghai Joyingmed Sensory Stimulation Lab
Subarachnoid Hemorrhage, Aneurysmal, Cognitive Dysfunction
03/25
03/25
NCT06356506: A Study on Factors of Biochemical Response in Autoimmune Hepatitis

Not yet recruiting
N/A
630
RoW
Beijing Friendship Hospital
Autoimmune Hepatitis
05/34
05/34
OHAVM, NCT04136860: Long-term Outcomes After Different Management Strategies for High-level Cerebral Arteriovenous Malformation

Recruiting
N/A
1000
RoW
Beijing Tiantan Hospital, Peking University International Hospital
Arteriovenous Malformation of Brain
11/24
12/24
NCT04662918: Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding

Recruiting
N/A
3000
Europe, US, RoW
Xingshun Qi
GastroIntestinal Bleeding
12/24
12/24
NCT05885828: The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes

Recruiting
N/A
200
RoW
White bread, Breakfast A, Whole wheat bread, Breakfast B, Plant-based diet, Conventional diabetic diet, Follow-up visit every 1-2 years
Westlake University, Hangzhou Third People's Hospital
Type 2 Diabetes
12/24
12/33
NCT05720299: A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila on Insulin Resistance Among Obese Subjects.

Recruiting
N/A
120
RoW
Treatment with Akkermansia muciniphila, Treatment with placebo
Yu Chen
Obesity Associated Disorder
12/24
12/24
DILI-PM, NCT05060289: A Prognostic Model for Drug-induced Liver Injury in China

Recruiting
N/A
3000
RoW
Beijing Friendship Hospital
Drug-induced Liver Injury
12/26
12/28
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma

Recruiting
N/A
300
RoW
Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Hepatocellular Carcinoma
03/26
03/26
BHC-C, NCT05961748: Registry of Multicenter Brain-Heart Comorbidity in China

Recruiting
N/A
100000
RoW
Multi-disciplinary assessment
Beijing Tiantan Hospital
Ischemic Heart Disease, Cardiac Arrest, Atrial Fibrillation, Heart Failure, Aortic Diseases, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Cerebral Infarction, Occlusion and Stenosis of Precerebral Arteries, Occlusion and Stenosis of Cerebellar Arteries, Cerebral Aneurysm, Moyamoya Disease, Arteriovenous Malformation of Cerebral Vessels
12/32
12/32
TCCT, NCT04484129: MDR-TB Close Contacts Tracing in China ( Study)

Not yet recruiting
N/A
500
RoW
Huashan Hospital
Multidrug Resistant Tuberculosis
12/22
12/22
LongTEAM, NCT04785976: Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage

Recruiting
N/A
5000
RoW
Surgical clipping and endovascular coiling
Beijing Tiantan Hospital, Peking University International Hospital
Aneurysmal Subarachnoid Hemorrhage
03/32
04/32
Shi, Yan
INDOMAP, NCT03547232: Rectal Indomethacin as Early Treatment for Acute Pancreatitis ( Trial)

Recruiting
4
1428
RoW
Indomethacin SR, YINDUOMEIXIN, Placebos, sham
Peking Union Medical College Hospital
Acute Pancreatitis, Complication, Mortality Rate, Organ Failure, Multiple
06/28
06/30
NCT04264676: Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer

Recruiting
2
294
RoW
Metronidazole Oral Tablet, Placebo oral tablet
Shanghai Jiao Tong University School of Medicine, Shanghai Municipal Commission of Health and Family Planning, Ruijin Hospital, Fudan University, Shanghai Zhongshan Hospital, Shanghai Shenkang Hospital Development Center
Colorectal Cancer Stage II, Colorectal Cancer Stage III
03/23
03/25
TiTanec, NCT05013268: Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma

Not yet recruiting
1
15
RoW
Tislelizumab, paclitaxel/docetaxel, cisplatin/carboplatin
Ruijin Hospital
Cervical Squamous Cell Carcinoma
06/22
12/22
NCT05049265: Clinical Study of JS007 in Patients With Advanced Solid Tumors

Recruiting
1
42
RoW
JS007
Shanghai Junshi Bioscience Co., Ltd.
Patients With Advanced Solid Tumors
09/22
09/22
NCT05171530: Lenvatinib With Taxane Drugs Treatment for Advanced Gastric Cancer

Recruiting
1
19
RoW
Lenvatinib plus taxane drugs
Ruijin Hospital
HER2-negative Advanced Gastric Cancer
12/22
06/23
NCT06209385: A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors

Recruiting
1
157
RoW
YZJ-5053 tablets, SHY-1901
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Solid Tumor
10/27
01/28
NCT05169697: A Study to Assess YH002 in Combination with YH001 in Subjects with Advanced Solid Tumors

Completed
1
6
RoW
A:YH002+YH001, B:YH002+YH001, YH002+YH001
Eucure (Beijing) Biopharma Co., Ltd
Advanced Solid Tumor
07/23
07/23
NCT03273920: Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer

Not yet recruiting
N/A
1110
RoW
Robotic distal gastrectomy with D2 nodal dissection, Laparoscopic distal gastrectomy with D2 nodal dissection
Southwest Hospital, China, Chinese PLA General Hospital, West China Hospital, Xijing Hospital of Digestive Diseases, Nanjing PLA General Hospital, Peking University Cancer Hospital & Institute, Qingdao University, Fujian Medical University Union Hospital, Central South University, The First Affiliated Hospital of Nanchang University, Sun Yat-sen University, Wuhan Union Hospital, China, Jilin Provincial Tumor Hospital, Lanzhou General Hospital of PLA
Gastric Cancer
09/19
09/22
NCT04714918: Chinese CKD-MBD Prevalence Survey (CRISS-MBD)

Recruiting
N/A
10254
RoW
Limeng Chen
Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder
12/24
12/24
NCT04968028: Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament

Recruiting
N/A
164
RoW
ACAF, Anterior Controllable Antedisplacement and Fusion, Laminoplasty
Shanghai Changzheng Hospital, Changhai Hospital, Shanghai 6th People's Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Tongji Hospital, Peking University Shenzhen Hospital, The Second Affiliated Hospital of Harbin Medical University, Xuanwu Hospital, Beijing, Jining Medical University, The Affiliated Hospital of Qingdao University, Shanxi Bethune Hospital, Tang-Du Hospital
Ossification of Posterior Longitudinal Ligament, Cervical Spondylosis With Myelopathy
07/25
12/26
NCT05181787: Biomarkers of Atrial Fibrillation Complicated With Stroke Based on Proteomics and Metabolomics

Recruiting
N/A
200
RoW
Proteomics, Metabolomics
Yue LI
Atrial Fibrillation, Stroke
12/23
12/23
ZN-2024349-01, NCT06643247: Electroacupuncture Regulation of Immune Cells in Herpes Zoster

Not yet recruiting
N/A
8
NA
Drug, Medication, Electroacupuncture, EA
First People's Hospital of Hangzhou
Herpes Zoster, Electroacupuncture, Immune
12/25
12/25
NCT06063954: Two Electroacupuncture Waveforms for Different Severity Groups of Bell Palsy

Recruiting
N/A
120
RoW
electroacupuncture
The Third Affiliated hospital of Zhejiang Chinese Medical University, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang University
Bell Palsy
12/25
12/25
NCT06760858: A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer

Recruiting
N/A
122
RoW
Tislelizumab, SOX, HIPEC
Southwest Hospital, China
Gastric Cancer, Gastroesophageal Junction Cancer
09/28
09/29
NCT05181774: Prediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabolomics

Recruiting
N/A
100
RoW
Proteomics, Metabolomics
Yue LI
Atrial Fibrillation, Bleeding, Anticoagulant Therapy
12/23
12/23
Wang, Lihua
NCT04263922: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

Recruiting
4
466
RoW
Huaiqihuang granules, B12000050755, Valsartan capsule, H20030638
The First Affiliated Hospital of Dalian Medical University, Huazhong University of Science and Technology, LinkDoc Technology (Beijing) Co. Ltd.
Renal Insufficiency, Chronic
10/25
03/26
SHINY, NCT06157502: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke

Recruiting
3
1380
RoW
Shuxuening Injection, Placebo
Beijing Tiantan Hospital
Ischemic Stroke, Acute
06/25
12/26
NCT05975268: A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

Active, not recruiting
3
747
RoW
JS005 (recombinant humanized monoclonal antibody against IL-17A)
Shanghai Junshi Bioscience Co., Ltd.
Moderate to Severe Chronic Plaque Psoriasis
08/25
10/25
NCT06319846: Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)

Recruiting
3
4674
RoW
Tirofiban, Placebo
Beijing Tiantan Hospital
Ischemic Stroke, Acute, TIA, Symptomatic Intracranial Artery Stenosis
10/25
12/26
HDM3014-301, NCT06648772: Efficacy and Safety of Roflumilast Cream 0.3% in Subjects with Plaque Psoriasis: a Phase 3 Study

Recruiting
3
189
RoW
Roflumilast Cream 0.3%, Zoryve, Vehicle cream
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Plaque Psoriasis
06/25
07/25
NCT06631170: Efficacy and Safety of Roflumilast Cream in Subjects with Atopic Dermatitis

Recruiting
3
351
RoW
Roflumilast Cream 0.15%, Vehicle cream
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Atopic Dermatitis (AD)
08/25
08/25
NCT06413654: A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Recruiting
2/3
132
RoW
B001, Placebo
Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd
Neuromyelitis Optica Spectrum Disorders
10/27
02/29
NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Recruiting
2
129
RoW
ICP-488 Tablets, ICP-488 Placebo
Beijing InnoCare Pharma Tech Co., Ltd.
Moderate to Severe Plaque Psoriasis
10/24
11/24
NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

Recruiting
2
320
RoW
SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan
Shanghai Pharmaceuticals Holding Co., Ltd
Diabetic Kidney Disease
06/25
06/25
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis

Suspended
2
279
Europe, US, RoW
zetomipzomib, KZR-616, placebo, matching placebo
Kezar Life Sciences, Inc.
Lupus Nephritis
05/26
07/26
TESTING-ON, NCT05434325: TESTING -ON Post-Trial ObservatioNal Cohort Study

Recruiting
N/A
366
Canada, RoW
The George Institute, Peking University Institute of Nephrology
IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases
07/27
07/27
NCT05454397: A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

Recruiting
N/A
2000
RoW
Observational study, no intervention
Nanfang Hospital of Southern Medical University, First Affiliated Hospital of Fujian Medical University, Yantai Yuhuangding Hospital, The First Hospital of Jilin University, Qilu Hospital of Shandong University, ZHEJIANG PROVINCE XIAOSHAN HOSPITAL, The First People's Hospital of Wenling, Ganzhou People's Hospital, Affiliated Hospital of Jining Medical hospital, Henan Provincial People's Hospital, Zhongda Hospital Southeast University, The Second Affiliated Hospital of Harbin Medical University, The First people's Hospital of Kunshan, The 2nd Affiliated Hospital of Wenzhou Medical University, THE FIRST PEOPLE'S HOSPITAL OF JIASHAN, The First Affiliated Hospital of Xi'an Jiaotong University Medical College, Fujian Province Zhangzhou Hospital, People's Hospital of Chongqing, Nanjing Zijin Hospital, Hangzhou Red Cross Hospital, Wenzhou Hospital of Chinese Medicine, Kaifeng Central Hospital, First Affiliated Hospital of Guangxi Medical University, Zhongshan Hospital of Xiamen University, Xi'an Encephalopathy of Traditional Chinese Medicine Hospital, 903 Hospital of the Chinese People's Liberation Army Joint Logistics and Security Forces, Xiangya Hospital of Central South University, Second Affiliated Hospital of Suzhou University, Tongji Hospital, The Affiliated Hospital o fQingdao University, The First Affiliated Hospital of Anhui Medical University, Yancheng Third People's Hospital, Linyi People's Hospital, Dongfang Hospital of Beijing University of Chinese Medicine, Affiliated Hospital of Qingdao University
Acute Stroke
10/22
10/23
TIAN, YE
CSPPT2-TT, NCT04974151: China Stroke Primary Prevention Trial 2 for Participants with Hypertension and MTHFR 677 TT Genotype

Recruiting
4
24000
RoW
Amlodipine besylate, Amlodipine, Amlodipine besylate And Folic Acid, Amlodipine Folic Acid, Anye, 5-methyltetrahydrofolate (5-MTHF), 5-MTHF, Amlodipine placebo, Amlodipine (dummy), Amlodipine folic acid placebo, Amlodipine folic acid (dummy), 5-MTHF Placebos, 5-MTHF (dummy)
Shenzhen Ausa Pharmed Co.,Ltd, Peking University First Hospital, Second Affiliated Hospital of Nanchang University, The First People's Hospital of Lianyungang, The Affiliated Hospital Of Guizhou Medical University, Lianyungang Oriental Hospital, Tengzhou Central People's Hospital, First Affiliated Hospital Bengbu Medical College, H & J CRO International, Inc., Shenzhen Prospective Medical Technology Co., LTD
Hypertension, MTHFR 677 TT Genotype
06/29
06/29
CSPPT2-CC/CT, NCT04974138: China Stroke Primary Prevention Trial 2 for Participants with H-type Hypertension and MTHFR 677 CC/CT Genotype

Recruiting
4
32000
RoW
Amlodipine besylate, Amlodipine, Amlodipine besylate and folic acid, Amlodipine folic acid, Anye, Amlodipine placebos, Amlodipine (dummy), Amlodipine-folic acid placebos, Amlodipine-folic acid (dummy)
Shenzhen Ausa Pharmed Co.,Ltd, Peking University First Hospital, Second Affiliated Hospital of Nanchang University, The First People's Hospital of Lianyungang, The Affiliated Hospital Of Guizhou Medical University, Lianyungang Oriental Hospital, Tengzhou Central People's Hospital, First Affiliated Hospital Bengbu Medical College, H & J CRO International, Inc., Shenzhen Prospective Medical Technology Co., LTD
Hypertension, MTHFR 677 CC or CT Genotype, Elevated Plasma Homocysteine (Hcy≥10µmol/L), Insufficient Plasma Folate Levels (<12ng/mL)
06/29
06/29
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo, Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
NCT06145230: A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups

Recruiting
N/A
430
RoW
Wang Guiyu
Colorectal Cancer, Age Problem
10/24
12/24
NCT06628531: SLI & Pulmonary HA Deposition After SAH

Not yet recruiting
N/A
24
RoW
Tianjin Medical University
Subarachnoid Haemorrhage (SAH)
09/25
09/27
Asgctsis, NCT05424978: Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an

Recruiting
N/A
3600
RoW
Standardized green channel treatment methods for stroke
Xi'an No.3 Hospital
Acute Ischemic Stroke, Thrombolysis, Endovascular Treatment
07/25
07/28
NCT06124391: Novel Subtypes of Polycystic Ovary Syndrome

Recruiting
N/A
50000
Europe, US, RoW
Long-term follow-up
Shandong University
Polycystic Ovary Syndrome
12/25
12/25
Tu, Ping
NCT06285370: A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy

Recruiting
4
20
RoW
Mogamulizumab
Kyowa Kirin China Pharmaceutical Co., Ltd.
Cutaneous T-Cell Lymphoma
10/25
01/26
Pan, Ling
NCT04263922: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

Recruiting
4
466
RoW
Huaiqihuang granules, B12000050755, Valsartan capsule, H20030638
The First Affiliated Hospital of Dalian Medical University, Huazhong University of Science and Technology, LinkDoc Technology (Beijing) Co. Ltd.
Renal Insufficiency, Chronic
10/25
03/26
TQ05105-â…¡-01, NCT05020652: A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis

Recruiting
2
105
RoW
TQ05105 tablets, Hydroxycarbamide tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Moderate and High Risk Myelofibrosis
03/23
09/23
Xu, Jianguo
C-BSEAL-002, NCT06276543: Bactiseal Catheter Safety Registry Study

Recruiting
N/A
200
RoW
antibiotic-impregnated catheter
Integra LifeSciences Corporation
Hydrocephalus
07/26
12/26
 

Download Options